Afrezza 12IU Cartridge 30's is a rapid-acting inhaled insulin used to manage blood sugar levels around meals in people with type 1 and type 2 diabetes. Many patients compare the Afrezza 12IU Cartridge 30's price before starting therapy. It contains dry powder human insulin and is taken using the Afrezza inhaler, not a reusable pen or injection. Insulin helps glucose move from the blood into the body’s cells for energy. When this process is impaired, blood sugar levels rise and can cause long-term health complications. The Afrezza 12IU Cartridge uses include controlling post-meal blood sugar spikes when oral medicines or lower insulin doses are not sufficient. Doctors may assess Afrezza 12IU vs 8IU efficacy based on meal size, carbohydrate intake, and glucose readings. For dose adjustments, clinicians often refer to an Afrezza 12 unit dose conversion table to match inhaled insulin needs with previous injectable insulin doses. Many patients also ask, is 12IU Afrezza safe for type 1 diabetes, and it is generally prescribed with basal insulin under medical supervision. Compared to injectable insulin, patients sometimes notice differences in weight changes. Clinical observations suggest Afrezza weight gain vs injectable insulin may be lower in some individuals, although results vary. Like all insulin therapies, monitoring is essential, and possible Afrezza 12IU side effect includes cough, throat irritation, low blood sugar, or breathing discomfort. In India, patients who plan to buy Afrezza insulin online should ensure it is sourced from a licensed pharmacy with a valid prescription, as the Afrezza 12IU Cartridge 30's price can vary. Before starting Afrezza 12IU Cartridge 30's, inform your doctor about any lung conditions, as well as liver, kidney, or heart problems. Blood sugar needs can change during illness, pregnancy, or medication adjustments, so regular follow-up with your healthcare provider is important.